Next Article in Journal
Open-Label Phase II Study of Olokizumab in Adolescent Patients with Polyarticular Juvenile Idiopathic Arthritis: Results of the 24-Week Treatment Period
Previous Article in Journal
Unraveling Cannabidiol’s Bidirectional Regulation of Melatonin Pharmacokinetics via PEPT1/CYP1A2: Mechanistic Insights and Quantitative Projections
Previous Article in Special Issue
Advances in Near-Infrared BODIPY Photosensitizers: Design Strategies and Applications in Photodynamic and Photothermal Therapy
 
 
Review

Article Versions Notes

Pharmaceuticals 2026, 19(1), 81; https://doi.org/10.3390/ph19010081 (registering DOI)
Action Date Notes Link
article pdf uploaded. 30 December 2025 17:09 CET Version of Record https://www.mdpi.com/1424-8247/19/1/81/pdf
Back to TopTop